SAM
SUPN icon

Smartleaf Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Smartleaf Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Hold
592
– – ﹤0.01% 1834
2026
Q1 		$29.2K Sell
592
-555
-48% -$28.3K ﹤0.01% 1760
2025
Q4 		$57.2K Buy
1,147
+10
+0.9% +$486 ﹤0.01% 1481
2025
Q3 		$54.1K Buy
1,137
+268
+31% +$10.8K ﹤0.01% 1358
2025
Q2 		$27.1K Sell
869
-288
-25% -$9.23K ﹤0.01% 1430
2025
Q1 		$37.4K Sell
1,157
-110
-9% -$3.9K ﹤0.01% 1297
2024
Q4 		$46.8K Buy
1,267
+870
+219% +$30.6K ﹤0.01% 1211
2024
Q3 		$12.2K Buy
397
+196
+98% +$6.12K ﹤0.01% 1646
2024
Q2 		$5.4K Buy
+201
New +$5.83K ﹤0.01% 1761

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Smartleaf Asset Management's SUPN Position: Q2 2026 in Review

Smartleaf Asset Management held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 592 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Smartleaf Asset Management first reported a position in SUPN in Q2 2024 and has held it in 9 quarters since. The position peaked at $57.2K in Q4 2025. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Smartleaf Asset Management held 592 shares of Supernus Pharmaceuticals worth $27.7K as of Q2 2026.
  • Smartleaf Asset Management left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1834 holding.
  • Smartleaf Asset Management first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Supernus Pharmaceuticals position peaked at $57.2K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.